ORBIMED ADVISORS LLC is an institutional investment manager that files quarterly 13F reports with the SEC. As of Q1 2026, the fund manages $5.0B in reported equity holdings across 110 positions. The largest holdings are EWTX (9.7%), ELVN (6.2%), MDXH (5.7%), LLY (4.3%), RCEL (3.9%). The portfolio is concentrated in Other (86.7%), Healthcare (13.3%). Data sourced from SEC EDGAR 13F filings (CIK 1055951).